KYMR - Kymera Therapeutics, Inc.

📈 Is growth accelerating? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Revenue Growth YoY (%)	55.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+594%)	-61.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-865%)	-26.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-426%)	-55.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-791%)	114.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1335%)	-84.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1157%)	-20.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-361%)	55.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+592%)	8.7% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+8%)	196.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2359%)	-50.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-731%)	43.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+443%)	-1.6% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-120%)	5.7% Fair ↑ Fair Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-29%)	-53.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-763%)	-37.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-573%)	-48.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-707%)	19.5% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+143%)	39.9% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+399%)	463.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+5690%)	445.6% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+5470%)	597.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+7369%)	1429.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+17772%)	—	—	—	—	—	—
EPS Growth YoY (%)	13.4% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-10.1% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-14.6% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-63.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-18.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-256.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	8.9% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	13.4% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	1.4% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	57.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-13.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	14.1% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	—	11.9% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-41.1% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-41.8% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-5.6% Weak ↑ Weak Improving Year-over-year change in net income	-22.9% Weak ↑ Weak Improving Year-over-year change in net income	-31.5% Weak ↑ Weak Improving Year-over-year change in net income	-82.1% Weak ↑ Weak Improving Year-over-year change in net income	-35.1% Weak ↑ Weak Improving Year-over-year change in net income	-392.4% Weak ↓ Weak Declining Year-over-year change in net income	-18.2% Weak ↓ Weak Declining Year-over-year change in net income	-8.4% Weak ↓ Weak Declining Year-over-year change in net income	-18.6% Weak ↓ Weak Declining Year-over-year change in net income	58.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-22.9% Weak ↓ Weak Declining Year-over-year change in net income	3.6% Caution ↑ Caution Improving Year-over-year change in net income	-11.6% Weak ↑ Weak Improving Year-over-year change in net income	-2.8% Weak ↑ Weak Improving Year-over-year change in net income	-50.5% Weak ↑ Weak Improving Year-over-year change in net income	-63.2% Weak ↑ Weak Improving Year-over-year change in net income	-180.6% Weak ↓ Weak Declining Year-over-year change in net income	-167.2% Weak ↓ Weak Declining Year-over-year change in net income	-257.9% Weak ↓ Weak Declining Year-over-year change in net income	-76.3% Weak ↓ Weak Declining Year-over-year change in net income	-19.6% Weak ↓ Weak Declining Year-over-year change in net income	-10.2% Weak Weak Year-over-year change in net income	30.1% Excellent Excellent Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	7.9% Fair ↓ Fair Declining Year-over-year change in free cash flow	—	52.8% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-15.5% Weak ↑ Weak Improving Year-over-year change in free cash flow	-49.6% Weak ↓ Weak Declining Year-over-year change in free cash flow	—	2.7% Caution ↓ Caution Declining Year-over-year change in free cash flow	17.4% Good ↑ Good Improving Year-over-year change in free cash flow	19.5% Good ↑ Good Improving Year-over-year change in free cash flow	—	-4.4% Weak Weak Year-over-year change in free cash flow	-2.9% Weak Weak Year-over-year change in free cash flow	—	—	12.1% Fair Fair Year-over-year change in free cash flow	-11.1% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	53.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-43.8% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-33.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-0.1% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	31.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-21.5% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-43.1% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	11.5% Good ↑ Good Improving Compound annual revenue growth over 3 years	-18.1% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	55.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-31.2% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	71.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	40.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	106.5% Excellent Excellent Compound annual revenue growth over 3 years	115.8% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	12.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	-25.8% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-28.2% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	28.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	45.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	32.2% Excellent Excellent Compound annual revenue growth over 5 years	31.5% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Operating Margin (%) (%)	-244.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1733%)	—	—	—	-336.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2345%)	—	—	-198.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1424%)	—	-40.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-369%)	—	-262.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1851%)	-478.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3292%)	-239.4% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1696%)	-469.9% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3233%)	-354.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2463%)	-383.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2659%)	-222.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1584%)	-140.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1039%)	-133.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-990%)	-70.4% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-569%)	-100.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-767%)	-55.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-471%)	-431.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2978%)	-328.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2287%)	—	—	—	—
Profit Margin (%) (%)	-201.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1779%)	—	—	—	-296.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2573%)	—	—	-164.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1467%)	-472.0% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4034%)	-30.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-350%)	—	-235.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2058%)	-432.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3703%)	-216.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1900%)	-450.2% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3852%)	-349.6% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3014%)	-381.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3277%)	-221.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1949%)	-140.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1271%)	-133.2% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1210%)	-69.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-683%)	-99.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-927%)	-55.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-558%)	-425.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3645%)	-318.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2758%)	—	—	—	—
FCF Margin (%) (%)	-259.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	-360.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	-185.7% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-456.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-7.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	-278.7% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	—	-247.3% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-371.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-345.0% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-423.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-254.4% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-184.7% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-168.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-122.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-168.2% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	—	-464.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-392.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—
FCF / Net Income (x)	1.29x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.33x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.21x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.13x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.25x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.19x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.17x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.14x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.11x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	1.15x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	1.31x Good ↓ Good Declining Free cash flow relative to reported net income Optimal: > 1x	1.26x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.76x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.70x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-16.19x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair → Fair Stable Free cash flow relative to reported net income Optimal: > 1x	1.23x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	-4.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-4.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.9% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-7.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-3.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.9% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-8.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	10.4% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	9.5% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	12.5% Good Good Return earned on debt + equity capital invested Optimal: > 10%	14.8% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-5.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-8.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-6.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-7.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-6.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-2.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	-4.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-130%)	-5.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-137%)	-8.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-158%)	-7.9% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-153%)	-8.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-156%)	-8.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-156%)	-7.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-147%)	-6.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-141%)	-6.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-146%)	-3.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-124%)	-13.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-189%)	-8.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-159%)	-8.9% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-159%)	-7.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-147%)	-8.4% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-156%)	-10.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-167%)	-8.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-157%)	-7.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-149%)	-5.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-139%)	-9.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-164%)	-4.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-132%)	-4.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-130%)	-2.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-118%)	13.0% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-13%)	11.7% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-22%)	15.5% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	18.1% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+20%)	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Interest Coverage (x)	-1294.68x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1305.28x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1114.71x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-1098.14x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-966.57x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1302.50x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-1335.63x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1242.07x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1180.22x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-410.89x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1554.30x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1668.58x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-871.65x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-702.36x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1181.11x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1020.25x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-802.89x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-653.73x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-550.71x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-824.33x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-548.71x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-473.41x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-351.43x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-457.81x Weak Weak Operating income divided by interest expense Optimal: > 5x	-330.79x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—
Net Debt (USD)	$-144.09M	$-357.01M	$-112.95M	$-335.82M	$-89.97M	$-120.26M	$-110.72M	$-67.61M	$-93.51M	$-109.97M	$-81.05M	$-52.39M	$-50.15M	$-68.39M	$-155.66M	$-76.91M	$-33.73M	$-47.98M	$-156.82M	$-84.90M	$-53.10M	$-31.00M	$-54.59M	$-60.97M	$-121.25M	$-76.02M	$-5.34M	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Revenue per Share (USD)	$0.35	—	$0.03	$0.14	$0.28	—	$0.05	$0.35	$0.15	—	$0.08	$0.28	$0.16	—	$0.18	$0.22	—	—	$0.40	$0.41	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.71	$-0.98	$-0.94	$-0.95	$-0.82	$-0.89	$-0.82	$-0.58	$-0.69	$-0.25	$-0.90	$-0.67	$-0.70	$-0.59	$-0.79	$-0.78	—	$-0.67	$-0.56	$-0.55	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.92	—	$-0.31	$-0.75	$-0.99	—	$-0.66	$-0.65	$-0.66	—	$-0.68	$-0.79	$-0.82	—	$-0.65	$-0.77	—	—	$-0.74	$-0.69	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$18.73	$19.42	$13.19	$13.77	$12.07	$12.88	$11.73	$9.37	$11.59	—	$6.77	$7.47	$8.36	—	$9.40	$7.69	$8.29	—	$9.53	$5.72	$6.13	—	—	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$18.73	$19.42	$13.19	$13.77	$12.07	$12.88	$11.73	$9.37	$11.59	—	$6.77	$7.47	$8.36	—	$9.40	$7.69	$8.29	—	$9.53	$5.72	$6.13	—	—	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	97.53M	—	87.30M	80.45M	80.15M	—	76.13M	73.06M	70.77M	—	58.42M	58.33M	58.19M	—	54.54M	51.77M	—	—	50.71M	45.09M	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$614.79M	$788.00M	$456.72M	$640.79M	$441.96M	$442.50M	—	—	$481.12M	—	—	—	$349.62M	—	—	—	$343.04M	—	—	—	$230.65M	—	—	—	—	—	—	—	—
Total Equity (USD)	$1.54B	$1.58B	$946.26M	$971.48M	$786.23M	$835.62M	$892.93M	$684.92M	$711.20M	$394.97M	$395.54M	$435.43M	$462.00M	$490.15M	$512.88M	$397.95M	$428.72M	$459.64M	$483.13M	$258.10M	$275.25M	$283.89M	$294.69M	$-107.29M	$-93.80M	$-74.41M	$-63.22M	$-52.08M	$-34.44M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	$34.37M	$2.87M	$2.76M	$11.48M	$22.10M	$7.39M	$3.74M	$25.65M	$10.29M	$47.88M	$4.73M	$16.51M	$9.47M	$16.14M	$9.55M	$11.51M	$9.62M	$15.28M	$20.34M	$18.52M	$18.70M	$12.79M	$14.53M	$3.29M	$3.43M	$1.83M	$950.00K	—	—
Depreciation Expense (USD)	$2.02M	$2.03M	$2.15M	$2.08M	$2.05M	$1.99M	$1.99M	$1.94M	$1.46M	$891.00K	$895.00K	$900.00K	$879.00K	$818.00K	$767.00K	$705.00K	$687.00K	$689.00K	$671.00K	$552.00K	$485.00K	$497.00K	$490.00K	$389.00K	$387.00K	$361.00K	$200.00K	—	—
Net Income, GAAP (USD)	$-69.23M	$-86.98M	$-82.17M	$-76.61M	$-65.58M	$-70.75M	$-62.49M	$-42.06M	$-48.56M	$-14.37M	$-52.87M	$-38.80M	$-40.93M	$-34.87M	$-43.00M	$-40.26M	$-36.68M	$-33.90M	$-28.58M	$-24.66M	$-13.07M	$-12.69M	$-7.99M	$-13.99M	$-10.93M	$-11.51M	$-11.42M	—	—
Operating Cash Flow (USD)	$-88.84M	$-66.75M	$-27.11M	$-59.88M	$-79.15M	$-61.78M	$-50.19M	$-42.94M	$-39.59M	$8.04M	$-31.65M	$-35.26M	$-43.97M	$-39.54M	$-34.27M	$-38.98M	$-40.30M	$-38.35M	$-37.26M	$-30.51M	$-22.82M	$-20.07M	$131.67M	$-11.41M	$-12.06M	$-10.80M	—	—	—

Kymera Therapeutics, Inc.

Analytical Summary

29-Year Financial Trajectory

Health Breakdown

Statement lens

Benchmark Lens

Percentile Rankings

Peer Comparison

Compare KYMR with peers